Overcoming Challenges

January 27th, 2014

With complex protocol design and clinical trial budgeting trends in the generics industry, Integrium relies on our strong relationships with sites for efficient site performance.

With Integrium's Pharmacokinetics unit, generic companies are able to use our 50+ bed facility to for Phase 1 clinical trials with ease.

Integrated Partnerships

January 27th, 2014

The importance of the CRO has grown as we create integrated partnerships with generics companies to help facilitate an increase in the speed-to-market approach. A CRO must show an improvement in efficiency, acceleration in clinical trial cycle time, and access to global patient populations if needed.

The Industry

January 27th, 2014

Continuously growing over the years, the generic drug industry has saved the U.S. health care system over $1.07 trillion from 2002-2011. According to the Food and Drug Administration, in 2010 alone, FDA-approved generics calculated to a savings of $3 billion every week.